Lv2
180 积分 2020-12-21 加入
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
3分钟前
待确认
The discovery of a potent PARP1 inhibitor Senaparib
4分钟前
已完结
Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors in Cancer Chemotherapy
1小时前
已完结
Modeling of Poly(ADP-ribose)polymerase (PARP) Inhibitors. Docking of Ligands and Quantitative Structure−Activity Relationship Analysis
1小时前
已完结
The molecular landscape of ETMR at diagnosis and relapse
2小时前
已完结
Converting cell death into senescence by PARP1 inhibition improves recovery from acute oxidative injury
2小时前
已完结
Full-length GSDME mediates pyroptosis independent from cleavage
3小时前
已完结
USP7 accelerates FMR1-mediated ferroptosis by facilitating TBK1 ubiquitination and DNMT1 deubiquitination after renal ischemia–reperfusion injury
19小时前
已完结
Phosphoinositide-Dependent Kinase 1 Provides Negative Feedback Inhibition to Toll-Like Receptor-Mediated NF-κB Activation in Macrophages
19小时前
已关闭
Expression of 3-phosphoinositide-dependent protein kinase 1 in colorectal cancer as a potential therapeutic target
19小时前
已完结
皖公网安备34019202002308
